ClinicalTrials.gov
ClinicalTrials.gov Menu

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00414284
Recruitment Status : Terminated (One subject's HIV RNA rebounded at week 12. A repeat PhenoSense GT combination resistance assay at week 12 revealed evolution in protease inhibitor resistance.)
First Posted : December 21, 2006
Last Update Posted : December 8, 2010
Sponsor:
Collaborator:
Abbott
Information provided by:
Community Research Initiative of New England

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 2007
  Actual Study Completion Date : April 2007